Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000507

Drug Information
NameDibucaine
SynonymsMLS000028425; MolPort-001-783-628; KBioSS_001408; Prestwick2_000076; 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide; QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN; Cinchocainum; CHEBI:247956; NCGC00016338-03; ST51037211; Dibucaine (USP); BRD-K99121711-003-02-3; N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide; KBio2_001408; NSC 159055; Cinchocainum [INN-Latin]; Nupercainal (VAN); 2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide; Cinchocaine hydrochloride; 4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-; SPBio_001121; Prestwick1_000076; Nupercaine; Nupercaine (TN); Nupercainal; Cincocainio [INN-Spanish]; Spectrum3_000384; BAS 00401270; BPBio1_000321; SMR000058391; N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide; Percamine; NINDS_000332; 85-79-0; KBio3_001387; 2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide; Cincainum; Dibucaine Base; 2-Butoxy-N-(.beta.-diethylaminoethyl)cinchoninamide; Spectrum_000928; D0513_SIAL; Cinchocaine (INN); 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-; C07879; alpha-Butyloxycinchoninic acid diethylethylenediamide; Cinchocaine; Prestwick_164; KBioGR_001049; Cincocaina [DCIT]; HSDB 3312; LS-53768; DivK1c_000332; 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide; Dibucain; dibucaine; 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide; InChI=1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24; AC-2093; Cincocaina; Prestwick0_000076; I08-0059; AC1L1F05; BSPBio_000291; Dibucaine [USP]; BSPBio_002167; CHEMBL1086; 2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide; Cincocainio; UNII-L6JW2TJG99; D00733; NSC159055; HMS1568O13; 2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide; KBio2_006544; SPBio_002212; KBio1_000332; CID3025; Prestwick3_000076; Spectrum5_000865; Cinchocaine HCL; 2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide; Sovcaine; Dermacaine; C20H29N3O2; Dibucainum; alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine; 4-22-00-02284 (Beilstein Handbook Reference); IDI1_000332; EINECS 201-632-1; Spectrum4_000505; 2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide; DB00527; BRD-K99121711-001-03-5; NCGC00016338-01; Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]-; NCGC00016338-02; MLS001148085; .alpha.-Butyloxycinchoninic acid diethylethylenediamide; KBio2_003976; Cinchoninamide, 2-butoxy-N-(2-(diethylamino)ethyl)-; D0513_FLUKA; CAS-85-79-0; AB00053453; BRN 0275489; WLN: T66 BNJ CO4 EVM2N2&2; 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide; Spectrum2_001001
Trade NameCincain; Nupercainal; Nupercaine; Sovcaine
IndicationAnesthetic
[ICD9: 338   ICD10: R52]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(2
4)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
InChIKeyPUFQVTATUTYEAL-UHFFFAOYSA-N
Canonical SMILESCCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC    
Therapeutic ClassAnesthetics
CAS NumberCAS 85-79-0
FormulaC20H29N3O2
PubChem Compound IDCID 3025.
PubChem Substance IDSID 10081.
SuperDrug ATC IDC05AD04; D04AB02; N01BB06; S01HA06; S02DA04
SuperDrug CAS ID000085790;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 006203 To Reference
Ref 2Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543